Top brokers name 3 ASX shares to sell today

Brokers are bearish on these ASX shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Yesterday I looked at three ASX shares brokers have given buy ratings to this week.

Unfortunately, not all shares are in favour with them right now. Three ASX shares that have just been given sell ratings by brokers are listed below. Here's why these brokers are bearish on them:

A young businesswoman looks shocked at what she's reading on the paperwork in her hand, with colleagues in the office in the background.

Image source: Getty Images

A2 Milk Company Ltd (ASX: A2M)

According to a note out of Macquarie, its analysts have retained their underperform rating and $5.40 price target on this infant formula company's shares. The broker notes that smaller rival Bubs Australia Ltd (ASX: BUB) reported a strong rebound in sales in the first quarter. While this could be good news for A2 Milk, Macquarie appears to believe that investors should wait for an update from the company before getting too excited. It notes that an investor briefing is scheduled late this month. The A2 Milk share price is fetching $6.72 today.

Evolution Mining Ltd (ASX: EVN)

A note out of Goldman Sachs reveals that its analysts have retained their sell rating and cut their price target on this gold miner's shares to $3.70. Goldman believes that Evolution's shares are expensive in comparison to peers. In addition, the broker has been looking at commodities and has updated its price expectations. Goldman has reduced its average gold price estimate for 2021 to US$1,850 per ounce (from US1,890 per ounce). The Evolution share price is trading at $3.94 today.

Pact Group Holdings Ltd (ASX: PGH)

Analysts at Morgan Stanley have retained their underweight rating and $3.30 price target on this packaging company's shares. This follows the release of a trading update that disappointed the market earlier this week. Though, it was largely in line with what the broker was expecting. One thing that did surprise Morgan Stanley was the company's decision to cancel the sale of its Contract Manufacturing business. The broker was expecting the sale of the struggling business to be a positive catalyst. The Pact share price is now trading below this price target at $3.09.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

a couple consider the advice from a man with documents laid out on a table and the man holding a tablet in his hand.
Financial Shares

3 ASX 200 financial shares to sell: experts

ASX 200 financial shares are down 2.5% over six months and up 2.1% in 2026-to-date.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

What is Morgans saying about Cochlear and Northern Star shares?

Here's what the broker is saying about these big names following their updates.

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy, hold, sell: NextDC, Hub24, PLS Group shares

The market is pessimistic about the next round of talks between the US and Iran.

Read more »

A team of people giving the thumbs up sign.
Broker Notes

5 ASX 200 shares with renewed buy ratings this week

Brokers have indicated continuing confidence in Cochlear, REA, and several other ASX 200 shares.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Broker reiterates buy ratings on 2 ASX shares

These ASX shares remain worth watching.

Read more »

Sell buy and hold on a digital screen with a man pointing at the sell square.
Broker Notes

After more than quadrupling investors' money in a year, are PLS shares still a buy?

A leading analyst delivers his outlook for the soaring PLS share price.

Read more »

A young man wearing a bright yellow jumper and glasses purses his lips together and moves them to the side of his face as he wonders about something.
Broker Notes

Buy, hold, or sell? Life360, Iress, Lynas Rare Earths shares

Experts reveal their views.

Read more »

Worried woman calculating domestic bills.
Broker Notes

Why did this broker just lower its outlook on this ASX 200 stock?

Despite a lowered outlook, attractive upside remains.

Read more »